Effects of ursodeoxycholic acid on ACE2 receptor and infection with SARS-CoV-2 in mice
10.16303/j.cnki.1005-4545.2024.09.10
- VernacularTitle:熊去氧胆酸对小鼠ACE2受体的影响及感染SARS-CoV-2的效果
- Author:
Zhuangzhuang SHI
1
;
Yue FENG
;
Rina SU
;
Junkui ZHANG
;
Lingjun FAN
;
Yuwei GAO
;
Tiecheng WANG
Author Information
1. 吉林农业大学动物医学院,吉林长春 130118
- Keywords:
severe acute respiratory syndrome coronavirus 2(SARS-CoV-2);
BALB/c mice;
ursode-oxycholic acid(UDCA);
angiotensin converting enzyme 2(ACE2)
- From:
Chinese Journal of Veterinary Science
2024;44(9):1914-1922
- CountryChina
- Language:Chinese
-
Abstract:
In the course of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infec-tion,to verify whether ursodeoxycholic acid(UDCA)can reduce angiotensin-converting enzyme 2(ACE2)receptor in BALB/c mice and reduce the risk of infection.UDCA was administered by in-tragastric administration to BALB/c mice for 7 d.During the treatment,the turbinate bones and lungs of mice were taken every day,and the changes of ACE2 content in the turbinate bones and lungs of mice were detected by ELISA.In addition,after 1,4 and 7 d of intragastric prophylaxis,BALB/c mice were infected with SARS-CoV-2 C57MA14 mouse adapted strain and SARS-CoV-2 Omicron DY1.1,respectively,after nasal inoculation,and viral load was detected on the turnings and lungs of mice 3 d after challenge to evaluate the preventive effect.In addition,UDCA was used to treat BALB/c mice infected with SARS-CoV-2 C57MA14 mouse adapted strain after nasal drops by gavage for 3 d,and the viral load of the mouse turbinate and lung was detected to evaluate the therapeutic effect.UDCA can decrease ACE2 content in turbinate and lung of BALB/c mice.How-ever,after 1,4 and 7 d of UDCA intragastric administration,there was no statistical difference in viral load in turbinate and lung of BALB/c mice between the prevention group and the virus con-trol group.There was no significant difference in the viral load of the turbinate and lung between the UDCA treatment group and the viral control group.UDCA could reduce the ACE2 content in the turnings and lungs of aged BALB/c mice,but the daily dose and duration of UDCA treatment had no significant effect on the mice infected with SARS-CoV-2 C57MA14 mouse adapted strain and SARS-CoV-2 Omicron DY1.1.
